期刊文献+

聚乳酸-羟基乙酸超声造影剂增强兔淋巴结显像的初步实验研究 被引量:10

Effects of poly lacticoglycolic acid ultrasound contrast agent on tumor lymph node imaging
原文传递
导出
摘要 目的 研究自制聚乳酸-羟基乙酸(poly lacticoglycolic acid,PLGA)超声造影剂增强兔肿瘤淋巴结显像的效果及其相关机制。方法采用乳液-溶剂蒸发法制备PLGA超声造影剂;经免大腿皮下注射VX2肿瘤细胞制备肿瘤淋巴结模型,肿瘤细胞生长14~18d后用于超声显像。通过问歇谐波显像观察PLGA造影剂对胭窝肿瘤淋巴结的增强作用,并通过巨噬细胞试验初步探讨增强淋巴结超声显像的相关机制。结果PLGA超声造影剂粒径分布均匀;可以明显增强肿瘤淋巴结显像;细胞试验表明巨噬细胞可以大量吞噬PLGA超声造影剂。结论PLGA超声造影剂是一种良好的肿瘤淋巴结显影剂。淋巴结内巨噬细胞吞噬造影剂后导致造影剂在淋巴结内滞留与聚集可能是其能够明显增强淋巴结显影的机制之一。 Objective To study the effects of poly lacticoglycolic acid(PLGA) ultrasound contrast agent on tumor lymph node imaging and its mechanism. Methods PLGA ultrasound contrast agent was made by double emulsion method; VX2 tumor cells were harvested from carrier rabbits and inoculated in the thigh of healthy New Zealand White rabbits. Implants were allowed to grow for 14 to 18 days before imaging. Popliteal lymph nodes were imaged as the injection sites were massaged. And macrophages were used to investigate the mechanism for lymph node enhancement. Results PLGA ultrasound contrast agent had a tight size distribution. Tumor lymph node was significantly enhanced by PLGA ultrasound contrast agent. Macrophages experiment showed that macrophages could phagocyte lots of PLGA ultrasound contrast agents. Conclusions PLGA ultrasound contrast agent is good for lymph node imaging. The possible mechanism for lymph node enhancement is that macrophages in lymph node can phagocyte lots of PLGA contrast agents, which causes the concentration of PLGA contrast agent in lymph node.
出处 《中华超声影像学杂志》 CSCD 2006年第1期54-57,共4页 Chinese Journal of Ultrasonography
基金 国家自然科学基金项目(30430230) 面上项目(30370402)
关键词 超声检查 造影剂 淋巴结 肿瘤 实验性 Ultrasonography Contrast media Lymph nodes Neoplasms, experimental
  • 相关文献

参考文献10

  • 1高云华.声学造影技术的研究进展[J].临床超声医学杂志,2002,4(6):357-359. 被引量:6
  • 2Mattrey RF,Kono Y,Baker K,et al.Sentinel lymph node imaging with microbubble ultrasound contrast material.Acad Radiol,2002,12(Suppl 1):S231-235.
  • 3郑元义,王志刚,冉海涛,李晓东,张群霞,景香香,任红.自制高分子材料超声造影剂及初步实验研究[J].中国超声医学杂志,2004,20(12):887-890. 被引量:19
  • 4Lathia D,Leodore L,Wheatley MA.Polymeric contrast agent with targeting potential.Ultrasonics,2004,42:763-768.
  • 5李晓东,王志刚,郑东,冉海涛,张群霞,郑元义,宫琳.自制包裹氟烷气体的表面活性剂类超声造影剂观察肝肿瘤血流实验研究[J].中华超声影像学杂志,2004,13(12):946-948. 被引量:2
  • 6Giuliano AE,Kirgan DM,Guenther JM,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg,1994,220:391-401.
  • 7Waeckerle-Men Y,Groettrup M.PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.Adv Drug Deliv Rev,2005,57:475-482.
  • 8RaviKumar MN,Bakowsky U,Lehr CM.Preparation and characterization of cationic PLGA nanospheres as DNA carriers.Biomaterials,2004,25:1771-1777.
  • 9Miller Dl,Thomas RM.Contrast-agent gas bodies enhance hemolysis induced by lithotripter shock waves and high-intensity focused ultrasound in whole blood.Ultrasound Med Biol,1996,22:1089-1095.
  • 10Song J,Chappell JC,Qi M,et al.Influence of injection site,microvascular pressure and ultrasound variables on microbubble mediated delivery of microspheres to muscle.J Am Coll Cardiol,2002,39:726-731.

二级参考文献35

  • 1Paelinck BP, Kasprzak JD. Contrast - enhanced echocardiongraphy: review and current role. Acta Cardiol, 1999,54:195 ~ 201.
  • 2Lindeer JR, Villanueva FS, Dent JM, et al. Assessment of resting perfusion with myocardial contrast echocardiography: theorefcal and practical conciderations. Am Heart J,2000,139(2 Pt 1):231 ~ 240.
  • 3Nagueh SF, Lakkis NM, He ZX, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol, 1998,32:225 ~ 229.
  • 4Tanaka S, Ioka T, Oshikawa O, et al. Dynamic sonography of hepatic tumors.AJR - Am - J - Roentgenol. 2001,177(4) :799 - 805.
  • 5Blomley M J, Sidhu PS, Cosgrove DO, et al. Do different types of liver lesions differ in their uptake of the microbubble constrast agent SHU 508A in the late liver phase? early exprience. Radiology.2001,220:661 ~ 667.
  • 6Burns PN, Wilson SR, Simpson DH, et al. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol, 2000,35: 58 ~ 71.
  • 7Albrecht T, Blomley MJ, Cosgrove DO, et al. Non - invasive diagnosis of hepatic cirrhosis by transis - time analysis of an ultrasound contrast agent.Lancet, 1999,353. (8):1 579~1 583.
  • 8Melany ML, Grant EG, Duerinckx AL, et al. Ability of a phase shift US contrast agent to improve imaging in the main renal arteries. Radiology, 1997;205:147 ~ 152.
  • 9Girard MS, Mattery RF, Baker KG, et al. Comparison of standard and second harmonic B - mode sonography in the detection of segmental renal infarction with sonographic contrast in a rabbit model. J Ultrasound Med, 2000,19 :185~192.
  • 10Hochmuth A, Fleck M, Hauff P, et al. First experiences in using a new ultrasotmd mode and ultrasound contrast agent in the diagnosis of blunt renal trauma: a feasibility study in animal model. Invest - Radiol, 20000,35: 205~211.

共引文献24

同被引文献121

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部